Authum Invests ₹36 Cr in Rivaara Labs

  Published 9 months ago

Authum Investment plans Rs 36 crore CCPS infusion and Rs 56.83 lakh purchase for Rivaara Labs' growth.

  • Rivaara Labs operates pathology, imaging, PCR testing, and genomic sequencing diagnostic service centres across India
  • Investment includes Rs 36 crore for 3.6 crore CCPS, plus Rs 56.83 lakh for acquiring existing securities of equity and convertible
  • Authum Investment focuses on loan provision, share trading, and strategic investments for a sustainable growth future

You might like these

Wipro Flags IT Demand Uncertainty

Volvo Cars Announces 3,000 Job Cuts

SBI Accuses Reliance Communications of Loan Fraud

Bankers See Strong Loan Demand Ahead

Harsha Engineers Bags Rs 117 Cr Deal

India's Forex Reserves Surge to Near Record High

GPT Wins Chambal Bridge Contract

News that matters the most ⚡